In 2003, Patent #6,630,507 was awarded to the US Department of Health and Human Services, asserting that cannabinoids are neuroprotectants and anti-inflammitory agents, useful in the prevention and treatment of stroke, trauma, auto-immune disorders, Parkinson’s, Alzheimer’s and HIV dementia as well as many other diseases.
The original patent is available online at the link below.